Acadia Pharmaceuticals Inc. (ACAD)

Last Three Months

30-Dec-23 -- 29-Mar-24

Time Period:
  • Three Months
  •  | 
  • Year

0 Net Amount
Buy:0--
Sell:0--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Insider Trading Sentiment: Sell
Sentiment Breakdown by Insider
0
(3)
0
(2)
0
(1)
31
0
3
+1
0
+2
0
+3

Two Year Chart

30-Mar-22 -- 29-Mar-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Last TransactionLast Three Months
SEC FilingTransactionInsiderSentimentCompanyHoldings ChangeBuy AmountSell AmountBuy Price RangeSell Price Range
27-Mar-24 7:58 PM
View: 
27-Mar-24
Sale (Planned)
($317.08K)
Davis Stephen
CEO
Director
Insider Trading Sentiment for Davis Stephen at Acadia Pharmaceuticals Inc. (ACAD):Acadia Pharmaceuticals Inc. - ACAD31%
90.72K to 118.84K
0
0
---- Show TxnsShow Insider Trades
27-Feb-24 6:07 PM
View: 
26-Feb-24
Planned Option Sale
($11.69K)
Kihara James
Principal Accounting Officer
Insider Trading Sentiment for Kihara James at Acadia Pharmaceuticals Inc. (ACAD):Acadia Pharmaceuticals Inc. - ACAD3%
11.03K to 11.39K
0
0
---- Show TxnsShow Insider Trades
27-Mar-24 8:00 PM
View: 
27-Mar-24
Sale (Planned)
($92.01K)
Teehan Brendan
EVP, COO, Head of Commercial
Insider Trading Sentiment for Teehan Brendan at Acadia Pharmaceuticals Inc. (ACAD):Acadia Pharmaceuticals Inc. - ACAD20%
30.39K to 36.34K
0
0
---- Show TxnsShow Insider Trades
09-Jan-24 6:00 PM
View: 
08-Jan-24
Option Sale
($17.68K)
Kim Austin D.
EVP,General Counsel, Secretary
Insider Trading Sentiment for Kim Austin D. at Acadia Pharmaceuticals Inc. (ACAD):Acadia Pharmaceuticals Inc. - ACAD2%
45.86K to 46.9K
0
0
---- Show TxnsShow Insider Trades
27-Mar-24 7:57 PM
View: 
27-Mar-24
Sale (Planned)
($97.27K)
Schneyer Mark C.
EVP, Chief Financial Officer
Insider Trading Sentiment for Schneyer Mark C. at Acadia Pharmaceuticals Inc. (ACAD):Acadia Pharmaceuticals Inc. - ACAD28%
20.49K to 26.18K
0
0
---- Show TxnsShow Insider Trades